Stay updated with breaking news from Seer Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 8, entitled, "A novel deep proteomic approach in human skeletal muscle unveils distinct molecular signatures affected by aging and resistance training."
Marquette Asset Management LLC acquired a new stake in Seer, Inc. (NASDAQ:SEER – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 49,264 shares of the company’s stock, valued at approximately $96,000. A number of other hedge funds and other institutional investors also […]
REDWOOD CITY, Calif., April 23, 2024 -- Seer, Inc. , a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results...
Morgan Stanley reaffirmed their equal weight rating on shares of Seer (NASDAQ:SEER – Free Report) in a research report report published on Tuesday, Benzinga reports. Morgan Stanley currently has a $7.00 price objective on the stock. Seer Trading Up 0.5 % SEER opened at $2.09 on Tuesday. The stock has a market capitalization of $133.40 […]
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer dataREDWOOD CITY, Calif., Feb. 29, 2024 -- Seer, Inc. , a leading life sciences company commercializing...